Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART
{{output}}
Background: In South African antiretroviral guidelines, selected patients failing second-line protease inhibitor (PI)-based therapy qualify for genotypic resistance testing - those with PI resistance receive darunavir-based third... ...
